Congenitally Abnormal Plasminogen in Juvenile Ischemic Cerebrovascular Disease

Background and Purpose Congenitally abnormal plasminogen is characterized by markedly decreased fibrinolytic activity and has been reported mainly in association with venous occlusive disease. Case Description We found three young adult patients (34, 45, and 27 years old at onset) with ischemic cerebrovascular disease, all of whom had congenital plasminogen abnormalities but no other known risk factors. Hemostatic tests of all three patients revealed plasma plasminogen activities at almost one half of the normal level despite normal plasma plasminogen antigen levels. They were found to be heterozygotes with abnormal plasminogen (normal Ala-601[GCT] to abnormal Thr-601[ACT]) by DNA sequence analysis after polymerase chain reaction. Conclusions Congenital plasminogen abnormalities could be one of the risk factors of juvenile ischemic cerebrovascular disease of the arterial as well as venous type.

[1]  A. Furlan,et al.  Stroke in a Young Adult With Familial Plasminogen Disorder , 1991, Stroke.

[2]  E. Davie,et al.  Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[4]  I. Scharrer,et al.  Investigation of a Congenital Abnormal Plasminogen, Frankfurt I, and Its Relationship to Thrombosis , 1986, Thrombosis and Haemostasis.

[5]  M. Osame,et al.  [Frequency and clinical significance of congenital plasminogen abnormality in cerebral infarction]. , 1986, Rinsho shinkeigaku = Clinical neurology.

[6]  Y. Sakata,et al.  Plasminogens Tochigi II and Nagoya: two additional molecular defects with Ala-600----Thr replacement found in plasmin light chain variants. , 1984, Journal of biochemistry.

[7]  J. Soria,et al.  Plasminogen Paris I: congenital abnormal plasminogen and its incidence in thrombosis. , 1983, Thrombosis research.

[8]  D. Dykes,et al.  Distribution of plasminogen allotypes in eight populations of the Western Hemisphere , 1983 .

[9]  K. Robbins,et al.  Human Plasminogen Variant Chicago III , 1982, Thrombosis and Haemostasis.

[10]  Y. Sakata,et al.  Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. Rutter,et al.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Nishimukai,et al.  Genetic Polymorphism of Plasminogen: A New Basic Variant (PLG B) and Population Study in Japanese , 1981, Vox sanguinis.

[13]  Y. Sakata,et al.  Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. , 1978, The Journal of clinical investigation.